Health
Global Times: Spring Festival hustle and bustle back, heralds vibrant year ahead
BEIJING, Jan. 20, 2023 /PRNewswire/ -- The Spring Festival of 2023 is destined to be unique, as it will be a year of return, of remembrance and letting go, of a new start to a more vibrant future after the country has optimized its COVID-19 responses, gradually walking out of the cloud of the epi...
2023-01-20 13:26
2260
BriSTAR Immunotech To Present its Novel Cell Therapy for Acute Myeloid Leukemia at the AACR Special Conference on AML and MDS
TORONTO, Canada and BEIJING, Jan. 20, 2023 /PRNewswire/ -- BriSTAR Immunotech, a clinical-stage cell therapy company, announced today it will showcase its T-cell receptors (TCR) and antigen receptor (STAR)-T cell therapy technology platform at theAmerican Association for Cancer Research (AACR) <...
2023-01-20 13:10
2214
$412.5 million! Mabwell Announces Exclusive Licensing Agreement with DISC MEDICINE, INC. for Innovative Drug Candidates of Hematologic Diseases
SAN DIEGO, Jan. 19, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced its wholly-owned subsidiary Mabwell Therapeutics has entered into an agreement with DISC MEDICINE, INC. ("Disc") about 9MW3011 (R&D code in t...
2023-01-20 09:50
2288
NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS
* QINLOCK® (ripretinib) now Medsafe approved for GIST patients in NZ * QINLOCK now being considered by PHARMAC for reimbursement * Data from the INVICTUS Phase 3 study shows QINLOCK reduces risk of disease progression or death by 85%1, 2 SINGAPORE and AUCKLAND, New Zealand, Jan. 19, 2023 /PR...
2023-01-20 02:00
2429
Hepagene Therapeutics Reports Positive Top-line Results for Phase 2a RISE Study of FXR Agonist HPG1860 in Patients with NASH
SHANGHAI, Jan. 19, 2023 /PRNewswire/ -- Hepagene Therapeutics, Inc. a clinical stage biopharmaceutical company focusing on developing novel therapies for patients with chronic liver diseases, today reported positive top-line results from the Phase 2a RISE clinical trial of HPG1860, a next gene...
2023-01-19 23:00
2400
Health In Tech Partners with 6 Degree Health and 90 Degree Benefits to Form a New Value-Based, Level-Funded Health Plan
STUART, Fla., Jan. 19, 2023 /PRNewswire/ -- Health in Tech ("HIT", or "the Company"), the industry-leading insurtech company that delivers disruptive innovation that reimagines self-funded health plans, today announced that the Company have partnered with 6 Degree Health and 90 Degree Benefits to...
2023-01-19 21:30
2396
Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment
SHANGHAI, Jan. 19, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), one of ...
2023-01-19 20:30
2246
Tigermed Completes Acquisition of Marti Farm
HANGZHOU, China and ZAGREB, Croatia, Jan. 19, 2023 /PRNewswire/ -- Tigermed (300347.SZ/3347.HK), a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, announced today the completion of its acquisition of Marti F...
2023-01-19 14:59
4233
China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List
SUZHOU, China, and ROCKVILLE, MD, Jan. 18, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), today an...
2023-01-19 11:45
2245
Everise Repositions Branding to Cement Evolution as End-to-End Customer Service Player
Launches new corporate slogan "Champions of customer happiness" and brand video PLANTATION, Fla., Jan. 18, 2023 /PRNewswire/ -- Leading customer service company Everise announced today the launch of its new brand repositioning, which includes a refreshed visual identity and the new brand tagline...
2023-01-18 22:00
2729
Lunit Highlights the Effectiveness of AI in Predicting Cancer Treatment Outcomes - Findings to be Presented at ASCO GI 2023
* Lunit to present two abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping * Lunit's presentations this year will highlight the effectiveness of Lunit SCOPE IO as a biomarker to predict treatment outcomes in liver and colon cancer SEOUL, South Korea, Jan. 18,...
2023-01-18 21:00
1822
Keymed Biosciences | The Latest Results from the Phase Ia Clinical Study of CMG901 was presented at the 2023 ASCO GI CANCERS SYMPOSIUM
CHENGDU, China, Jan. 17, 2023 /PRNewswire/ -- Keymed Biosciences Inc. (Stock Code: 02162 HK) is pleased to announce that the latest data from the Phase Ia dose-escalation trial of CMG901 (Claudin 18.2 antibody drug conjugate), a novel drug candidate, for advanced solid tumors will be presented as...
2023-01-18 09:52
1905
IASO Bio Raises Nearly $75 Million in Series C1 Funding
Approaches Commercialization of First Product NANJING and SHANGHAI, China and SAN JOSE, Calif., Jan. 17, 2023 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody p...
2023-01-18 08:00
1939
Asieris Appoints Dr. Linda Wu as Chief Development Officer
SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Asieris Pharmaceuticals(688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced thatLinda Wu, Ph.D. will join Asieris...
2023-01-18 07:00
2169
Tanso Biosciences Expands Its Line-up with 250 Mouse GPCRs
TOKYO, Jan. 17, 2023 /PRNewswire/ -- Tanso Biosciences, a leading provider of functional assays for G-protein-coupled receptors (GPCRs), is thrilled to announce a major expansion of its assay platform. Building upon its already extensive coverage of 300 human GPCRs, Tanso Biosciences has added 25...
2023-01-18 00:00
1957
Hybribio returns to Medlab Middle East 2023
GUANGZHOU, China, Jan. 17, 2023 /PRNewswire/ -- Medlab Middle East 2023 will be held at the World Trade Centre,Dubai, UAE from February 6 to 9. As one of the most well-known and professional exhibitions of trade platforms for the field of medical laboratory equipment and medical equipment, this e...
2023-01-17 22:30
2470
Health supplement information app Pillwork set for launch in the first-half year
SEOUL, South Korea, Jan. 17, 2023 /PRNewswire/ -- Pillwork releases its app
Pillwork that allows people to easily compare and purchase health supplements
in the first-half year.
2023-01-17 15:03
1508
Organon Is Recognized as Both "Top Employers China 2023" And "Best Workplaces™ in Greater China 2022"
SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Today, Organon China is proud to have been named the "2023 Top Employers inChina" and honored to receive "Best Workplaces™ inGreater China 2022" certificate, in recognizing its vision-driven company culture, diversity and inclusion, strong employer brand, a...
2023-01-17 13:06
1603
Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer
MANNHEIM, Germany, WATCHUNG, N.J. and SHANGHAI, Jan. 16, 2023 /PRNewswire/ -- Full-Life Technologies today announced the appointments ofSteffen Heeger, MD, PhD, as Chief Medical Officer (CMO) and Fa Liu, PhD as Chief Scientific Officer (CSO). Dr. Heeger has held senior oncology clinical developme...
2023-01-17 10:00
1947
FDA Accepts GMP Plasmid DMF of OBiO Technology
SHANGHAI, Jan. 16, 2023 /PRNewswire/ -- OBiO Technology (Shanghai) Corp., Ltd. ('OBiO', 688238.SH), a gene and cell therapy-focused contract research organization (CRO) and contract development and manufacturing organization (CDMO), recently announced that the United States Food and Drug Administ...
2023-01-17 08:00
2089
Week's Top Stories
Most Reposted
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
[Picked up by 350 media titles]
2024-09-18 11:30
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
[Picked up by 315 media titles]
2024-09-16 11:50
Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture
[Picked up by 283 media titles]
2024-09-19 14:00
Watsons-Marlow unveils Qdos™ H-FLO and WMArchitectTM :Innovating fluid solutions for the chemical and biopharmaceutical industries respectively
[Picked up by 274 media titles]
2024-09-19 08:00
MediSun Energy Teams Up with EEIC to Strengthen UAE's Water Security and Advance Sustainable Energy Solutions
[Picked up by 267 media titles]
2024-09-18 09:15
Most Read
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
2024-09-18 11:30
9152
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
2024-09-16 11:50
9003
MediSun Energy Teams Up with EEIC to Strengthen UAE's Water Security and Advance Sustainable Energy Solutions
2024-09-18 09:15
5254
Foton Motor & ZF: Hybrid Cooperation For Greener, advanced Commercial Vehicles
2024-09-18 10:37
5192
